Bill

Bill > SF638


IA SF638

A bill for an act relating to the taxation and regulation of alternative nicotine products and vapor products, creating the Iowa cancer research fund, and including effective date provisions.(Formerly SF 475, SSB 1137.)


summary

Introduced
04/22/2025
In Committee
Crossed Over
Passed
Dead

Introduced Session

91st General Assembly

Bill Summary

This bill regulates alternative nicotine products and vapor products and imposes taxes upon the wholesale sales price of such products, and makes numerous conforming changes to Code chapter 453A (cigarettes and tobacco-related products). The bill defines “nicotine analog” to mean a substance that has a chemical structure that is substantially similar to nicotine, or that has an effect on the central nervous system that is substantially similar to, or greater than, the effects of nicotine on the central nervous system. The bill adds “nicotine analog” to the definitions of “alternative nicotine product” and “vapor product”. The bill imposes a tax on alternative nicotine and vapor products upon any person engaged as a distributor of alternative nicotine products and vapor products, at the rate of 10 percent of the wholesale sales price of such products. In the alternative, a tax is imposed on the use or storage of alternative nicotine and vapor products, at the rate of 10 percent of the cost of such products, if the 10 percent tax on the wholesale sales price has not been paid. The revenue generated by the bill is credited to the new Iowa cancer research fund (fund), under the authority of the department of health and human services (HHS). The bill specifies moneys in the fund shall not be disbursed prior to July 1, 2026, and shall only be appropriated for purposes related to supporting and funding cancer research in the state. The bill requires HHS to develop an application process and guidelines for cancer researchers to receive moneys from the fund. The fund is not subject to reversion and moneys or earnings attributable to the fund are credited to the fund. The bill takes effect January 1, 2026.

AI Summary

This bill comprehensively updates Iowa's taxation and regulation of alternative nicotine and vapor products by introducing a new 10% tax on the wholesale sales price of these products and establishing an Iowa Cancer Research Fund. The bill defines a new term, "nicotine analog," as a substance with a chemical structure or effect on the central nervous system similar to nicotine, and expands existing definitions of alternative nicotine and vapor products to include these analogs. The revenues generated from the new tax will be specifically directed to the Iowa Cancer Research Fund, which will be administered by the Department of Health and Human Services and cannot be used until July 1, 2026. The fund is designed to support and fund cancer research in the state, with the department responsible for developing application processes and guidelines for researchers to access the funds. Additionally, the bill makes numerous conforming changes to existing tobacco-related laws, updating definitions, reporting requirements, and licensing provisions to incorporate alternative nicotine and vapor products. The bill is set to take effect on January 1, 2026, providing time for businesses and regulators to prepare for the new taxation and regulatory framework.

Committee Categories

Budget and Finance

Sponsors (0)

No sponsors listed

Other Sponsors (1)

Ways & Means (S)

Last Action

Fiscal note. (on 05/05/2025)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...